Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer

Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery

(2014) Takahiro Uenishi et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma

(2014) Michael N. Mavros et al.   JAMA Surgery

Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts

(2012) Hirohisa Okabe et al.   INTERNATIONAL JOURNAL OF CANCER

Current Knowledge on Pancreatic Cancer

(2012) Juan Iovanna et al.   Frontiers in Oncology

P-Cadherin Promotes Liver Metastasis and Is Associated with Poor Prognosis in Colon Cancer

(2011) Lichao Sun et al.   AMERICAN JOURNAL OF PATHOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance

(2010) Min A. Kim et al.   HUMAN PATHOLOGY

P-cadherin in adhesion and invasion: Opposite roles in colon and bladder carcinoma

(2010) Veerle Van Marck et al.   INTERNATIONAL JOURNAL OF CANCER

Cadherin Switching and Bladder Cancer

(2010) Richard T. Bryan et al.   JOURNAL OF UROLOGY

Advanced pancreatic carcinoma: current treatment and future challenges

(2010) Anastasios Stathis et al.   Nature Reviews Clinical Oncology

Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer

(2010) L W T Cheung et al.   ONCOGENE

Ectopic Expression of P-Cadherin Correlates with Promoter Hypomethylation Early in Colorectal Carcinogenesis and Enhanced Intestinal Crypt Fission In vivo

(2008) A. Milicic et al.   CANCER RESEARCH

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

(2008) R. W. Tothill et al.   CLINICAL CANCER RESEARCH

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

(2008) K. Imai et al.   CLINICAL CANCER RESEARCH

Cadherin switching dictates the biology of transitional cell carcinoma of the bladder:ex vivo andin vitro studies

(2008) RT Bryan et al.   JOURNAL OF PATHOLOGY